PETER GREVEN Your partner for pharmaceutical excipients

Similar documents
EMCOMPRESS. Calcium Hydrogen Phosphate, Ph.Eur., E 341(ii) Dibasic Calcium Phosphate, USP/NF, FCC. A Proven Excipient for more than 60 Years

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

f a c t s T C C T B Tricalcium citrate as excipient for direct compression

Tricalcium citrate as excipient for direct compression

1. How did the regulatory environment for excipients change over the years?

Formulation Development

Technical Magnesia Mineral compounds for technical applications

MEETING YOUR CHALLENGES TODAY AND TOMORROW. Avicel PH BINDERS

Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University

Providing insight into pharmaceutical formulations

Technical brochure FlowLac

Pharmaceutical grade quaternary ammonium compounds

Best Practices for Effective Tablet Lubrication

Baerlocher Additives. Hydrophobic Agents for Building Materials

AEROPERL Granulated fumed oxides

AEROPERL Granulated fumed oxides

Coathylene Polymer Powders

Maximizing Roller Compaction Benefits with Proper Excipient Selection

Your partner in the pharmaceutical industry

Formulation Development & CTM Manufacturing Services

EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016

DEVELOPMENT PHARMACEUTICS AND PROCESS VALIDATION

HealthCaps. Quality our Priority

Fine Chemicals. Aluminium Brazing Fluxes

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

Technical Bulletin MC-25. Microcrystalline Cellulose

PHARMACEUTICAL PACKAGING

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester

Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

Guidelines for Pharmaceutical Equivalence Requirements

DHT-4A - ACID SCAVENGER FOR POLYMERS UNIQUE PRODUCTS THROUGH UNIQUE TECHNOLOGIES

MINISTRY OF HEALTH AND SOCIAL SERVICES

Public Assessment Report. Scientific discussion. Natriumfusidat LEO 30 mg/100 cm 2 impregnated dressing. (Sodium fusidate) DK/H/2431/001/DC

DOW PuraGuard Propylene Glycol USP/EP. Your Security for Purity

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression. Katie Hewlett, Dow Gus LaBella, Colorcon

Baerlocher Additives. Metallic Stearates. we add character to plastics

Bringing ideas to life. Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

YOUR MICRONISATION AND MILLING PARTNER IN THE PHARMACEUTICAL INDUSTRY

Kollicoat IR. The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms. ExcipientFest.

Regulatory Assessment

WHOPAR. SCIENTIFIC DISCUSSION

Public Assessment Report. Scientific discussion. Progesteron GLF 100 mg and 200 mg soft capsules. (progesterone) NL/H/3415/ /DC

Technical brochure Milled and sieved lactose

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010

TASTE MASKING WITH COATINGS. Coating Technology 96 October 8-9, Presented by Ralph E. Pondell Corporate Secretary

AEROSIL and SIPERNAT Silica for Personal Care

PHARMACEUTICAL MANUFACTURING

GUIDANCE DOCUMENT Use of a Foreign-sourced Reference Product as a Canadian Reference Product

Tablet formulation design spaces for direct compression and roller compaction. QbD in Pharmaceutical Development: processes

AN INTRODUCTION TO SPHERONIZATION (MARUMERIZATION * )

SIPERNAT and AEROSIL products in the food industry. Industry Information II 2129

Seamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production

Methacrylic acid ethyl acrylate copolymer (1:1) dispersion 30 per cent (e.g. Kollicoat MAE 30 DP)

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group

Microbiological Consideration for Non-Sterile Pharmaceutical

At LATITUDE, we only do one thing, and we do it very well.

CONTACT US... Your Partner on the Path of...making a Healthier Mankind. Follow us. Scan for web.

SCIENTIFIC DISCUSSION

Lubricants and release agents for massive forming

Manufacturing Technology Committee Risk Management Working Group Risk Management Case Studies. Case No. RMWG-07. Space

Rahavard Tamin Pharmaceutical Co. (RTPC)

Applied Process Understanding in Drug Product Development

Roller Compaction: New trends, challenges and solutions

Pharma Ingredients & Services. Kollicoat IR White. Technical Information

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department

CGMP Requirements for Investigational Products

The All-in-One Tool. DORKAFILL Pro_Void multifunctional cost effective filler for premium-class dispersion paint

APEX HEALTHCARE BERHAD (COMPANY NO T)

SCIENTIFIC DISCUSSION

Public Assessment Report. Scientific discussion. Naproxennatrium Banner 220 mg capsules, soft (naproxen sodium) NL/H/2804/001/DC. Date: 28 April 2014

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET

Better wet granulation: development, scale-up and manufacture

APPLICATION FOR MARKETING AUTHORIZATION OF A PHARMACEUTICAL PRODUCT FOR HUMAN USE IN UGANDA

TABLETABILITY, COMPACTABILITY, AND COMPRESSIBILTY: WHAT S THE DIFFERENCE?

Pharma Ingredients & Services. Ludiflash. Technical Information

PHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

Continuous Manufacturing. Combined approved technologies swiss made. Prospekt Nr. 655

Developing Pharmaceutical Continuous Crystallization Processes - Knowledge & Gaps. Chris Price on behalf of the IMI team Product Development

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs

CURRENT CHALLENGES IN GLOBAL REGULATORY COMPLIANCE QUALITY OF PHARMACEUTICAL INGREDIENTS PHARMACOPOEIAL HARMONISATION PROCESS

Intertek Melbourn Company Presentation. MIBio 2016

ADVANTAGES OF MULTIPARTICULATES (PELLETS):

How to Identify Critical Quality Attributes and Critical Process Parameters

Kollidon The Original Setting new standards in stability, purity and patient safety.

SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced

Europe s new approach to assurance of API quality and its implications for manufacturers and producing countries

FROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities

Public Assessment Report. Scientific discussion. Hydrochlorothiazide Farmaprojects 12.5 mg and 25 mg tablets. (hydrochlorothiazide)

Your Best Partner. Tylose. for Building Materials. Product Information

Artemether/Lumefantrine 20/120mg tablets WHOPAR part 6 September 2010 (Cipla Ltd), MA064

MARIFARM LLC PRODUCTION ABOUT US

POLYSORBATE 80. Product Regulatory Data Sheet. J.T.Baker 4117 Polysorbate 80, NF, Multi-Compendial R

Transcription:

PETER GREVEN Your partner for pharmaceutical excipients Sustainability and the demand for renewable raw materials are becoming more and more important in many areas. As a middlesized family owned company we have always produced additives based on renewable raw materials and can look back to a long experience with these raw materials and associated production technologies. Oleochemical additives are among the most important excipients in the pharmaceutical industry. We began addressing these requirements many years ago and dedicated our production facility in Venlo (NL) to the manufacture of high-quality, vegetable stearates for pharmaceutical applications. The complexity of operations requires a continuous process of improvement and customisation. For decades we have embraced this challenge and became the market leader for pharmaceutical stearates in Europe. Our LIGAMED product portfolio offers a variety of high-quality additives which are dedicated to the needs and requirements of the pharmaceutical industry. In addition to the special physical and chemical characteristics of our products we focus on the strict adherence to regulatory requirements as well as strong technical service. Our LIGAMED grades cover an extensive range of applications in the pharmaceutical industry: Tableting agent Lubricant Flowability agent Separating agent Water repellent Stability improvement agent Emulsifying agent Gelling agent page 2

LIGAMED High Quality Excipients for the Pharmaceutical Industry Our LIGAMED product line offers outstanding quality and purity. Furthermore it is characterised by the following quality features and product advantages: Different products groups are produced on dedicated production lines to avoid cross contamination. LIGAMED grades are produced in accordance with IPEC PQG GMP conditions. The adherence to the strict regulations is supported by our EXCiPACT certificate. We comply with all major pharmacopeias: Ph.Eur, USP/NF, JP. Our products are available as Kosher and Halal certified grades. The special precipitated production process enables the high specific surface area of our products. Therefore, they are very efficient and the required dosage is low. Our LIGAMED products offer exceptional lubrication, release and separation abilities due to the high percentage of fine particles. High batch-to-batch consistency is guaranteed by constant supervision. Only the best vegetable based raw materials are used for our production. Usage of sustainably grown palm oil is important to us. Therefore we offer products based on RSPO certified raw materials. KOSHER HALAL EXCiPACT RSPO Mass Balance RSPO Segregated page 3

MAGNESIUM STEARATE Magnesium Stearate is the most widely used excipient within the pharmaceutical industry: It ranks first on the list of the Top Ten excipients used in solid oral dosage forms. How does LIGAMED Magnesium Stearate work? The crystal structure of high quality Magnesium Stearate is often pictured as a deck of cards. Due to the lamella structure Magnesium Stearate offers a very high specific surface area. LIGAMED MF-2-V 15kV, 12mm Blending process During the blending process with active ingredients, carriers or fillers, the plates of Magnesium Stearate dismantle from the decks, piece by piece, to coat other particles. LIGAMED MF-3-V 15kV, 12mm LIGAMED MF-2-V-BI 20kV, 12mm page 4

LIGAMED MF-2-V specific surface area: 6 10 m 2 /g, median particle size (D50): 7 11 μm This is our most widely used excipient for the production of tablets and capsules. Its high specific surface area and fine particles offer a high releasing speed during tablet pressing and consistent physical performance of the tablets such as hardness and dissolution profiles. Due to the exceptional high specific surface area, typical quantity used during formulation is low: 0,2 % to 1 % by tablet weight. In addition to the application as a tableting agent, this product is also used as a flowability agent for powder preblends, offering an efficient and low dosage in capsules. LIGAMED MF-3-V specific surface area: 8 12m 2 /g, median particle size (D50): 5 9 μm This grade is characterised by the same unique properties as LIGAMED MF-2-V but in addition MF-3-V offers an even higher specific surface area and a smaller median particle size. This product is preferred in applications where processing conditions are more critical and very fine excipients or herbal formulations are used. LIGAMED MF-2-V PREMIUM For highly complex pharmaceutical applications (e.g. inhalation medicine) we have developed our LIGAMED MF-2-V PREMIUM. This specialty grade has a high quality specification with additional tests for the fatty acid profile, particle size characterization and microbial count. LIGAMED MF-2-K LIGAMED MF-3-K LIGAMED MF-2-K and LIGAMED MF-3-K are produced in accordance with strict Kosher and Halal regulations and offer the respective certifications. These certificates are required for OTC pharmaceutical and nutraceutical preparations in Jewish and Arab cultures. Kosher and Halal certification has also become an important quality standard requested by European formulators. LIGAMED MF BLS LIGAMED MF BLS extends our existing product portfolio of Magnesium Stearates and is produced according to a special production process. Offering the specific characteristic of being water dispersible, this product is very suitable for the use within water-soluble drugs. LIGAMED MF-2-V-BI specific surface area: 6 8m 2 /g, median particle size (D50): 7 11 μm This variation of our LIGAMED MF-2-V offers a tighter specific surface area range in combination with the favourable crystalline structure of LIGAMED MF-2-V. This grade supports a lower dissolution profile and is used in special formulations as tablet coatings, where a low and stable viscosity is required. page 5

CALCIUM STEARATE Calcium Stearate possesses characteristics similar to Magnesium Stearate. Likewise it is physiologically safe and is used as a lubricant, flowability agent and water repellent. LIGAMED CPR-2-V specific surface area: 5 9 m 2 /g, median particle size (D50): 5 9 μm Some pharmaceutical formulations include vegetable based Calcium Stearate instead of Magnesium Stearate. Our LIGAMED CPR-2-V is a perfect choice encompassing all core LIGAMED pharmaceutical excipient principles. LIGAMED CPR-2-V is also used as a water repellent agent in the production of effervescent tablets. Premature reaction of the effervescent tablet is avoided by preventing unwanted absorption of moisture. LIGAMED CPR-2-K Our Calcium Stearate LIGAMED CPR-2-K is produced in accordance with strict Kosher and Halal regulations and offers the respective certifications. These certificates are required for OTC pharmaceutical and nutraceutical preparations in Jewish and Arab cultures. Kosher and Halal certification has also become an important quality standard requested by European formulators. STEARIC ACID Some formulations in the pharmaceutical industry are incompatible with Magnesium Stearate. For such formulations, Magnesium Stearate may be substituted by a high quality Stearic Acid. LIGAMED SA-1-V This grade is a very fine quality from vegetable origin Stearic Acid. It is used as a tableting and flowability agent in specific pharmaceutical formulations. LIGAMED SA-1-V is designed to support the high demands of the pharmaceutical industry, it complies with Ph.Eur & USP/NF regulations and is produced by a complex production process. page 6

RSPO certified Products Sustainability is very important to us. Therefore, parts of our LIGAMED product portfolio are available as RSPO certified grades. RSPO (Roundtable on Sustainable Palm Oil) is a non-profit association which introduced and develops global standards for sustainable palm oil. These products offer the same properties as the conventional grades but are based on RSPO Mass Balance or RSPO Segregated certified fatty acid. Our portfolio of certified products includes the following: LIGAMED MF-2-K-MB LIGAMED MF-2-K-BI-MB LIGAMED MF-3-K-MB LIGAMED SA-1-V-MB LIGAMED MF-2-K-SG LIGAMED CPR-2-K-SG LIGAMED SA-1-V-SG Addition LIGAMED Portfolio In addition to our LIGAMED product portfolio our brand PALMSTAR also offers selected products that meet the strict requirements of the pharmaceutical industry: PALMSTAR AL PHARMA PALMSTAR AL PHARMA is one of our Aluminium Stearates with the best gelling performance capabilities. It is very suitable as an emulsion stabilizer and viscosity increasing agent for creams and ointments. Additionally, pharmaceutical applications use it as an anti-caking agent or suspending agent. PALMSTAR AL PHARMA is in accordance with the European pharmacopeia. PALMSTAR ZPR-2-V PALMSTAR ZPR-2-V is a Zinc Stearate for pharmaceutical applications. It is used as an alternative lubricant if Magnesium and Calcium Stearate are incompatible with the API. Furthermore it can be used as a hydrophobing agent with antimicrobial properties for creams and as a stabiliser as well as a release agent for pharmaceutical plastics or rubber. page 7

Peter Greven GmbH & Co. KG Peter-Greven-Straße 20 30 53902 Bad Muenstereifel, Germany Phone +49 2253 313-0 Fax +49 2253 313-134 email sales@peter-greven.com www.peter-greven.com 04 GB 04/2018